Leaflet SORBISTERIT 15g powder for oral / rectal suspension in sachet
Indicated for: hyperkalemia
Route of administration: oral / rectal
Substance: calcium polystyrene sulfonate (potassium binder)
ATC: V03AE01 (Various | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia)
Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.
Calcium polystyrene sulfonate is used for the treatment of hyperkalemia, a condition characterized by high potassium levels in the blood. This medication works by binding potassium in the intestine and removing it from the body through stool.
It is often used in patients with kidney failure or other conditions that impair the body's ability to eliminate potassium. The medication is available as a powder administered orally or rectally, depending on the severity of hyperkalemia.
Treatment must be carried out under strict medical supervision, as excessive use may lead to electrolyte imbalances, such as hypocalcemia or hypermagnesemia. It is important to monitor potassium levels and other electrolytes during treatment.
Side effects may include nausea, constipation, abdominal discomfort, or, in rare cases, intestinal obstruction. Patients should inform their doctor of any adverse reactions.
General data about SORBISTERIT 15g
- Substance: calcium polystyrene sulfonate
- Date of latest medicines list: 01-01-2016
- Product code: W62039001
- Concentration: 15g
- Pharmaceutical form: powder for oral / rectal suspension in sachet
- Quantity: 30
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for calcium polystyrene sulfonate
Concentrations available for calcium polystyrene sulfonate
- 15g
- 500g